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ABSTRACT 
Polyrotaxanes are polymers that have macrocycles threaded onto them, analogous to beads threaded onto a 
string. These materials are used for a variety of different biomedical applications.
1-3
 The Thompson group has 
been developing 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) polyrotaxanes as therapeutics for the treatment of 
Niemann-Pick Type C (NPC) disease. NPC is a debilitating genetic disorder where cholesterol accumulates in 
the lysosomes of cells.
4
 Developing a scalable process is crucial for the advancement of these materials as NPC 
therapeutics. The goal of this project is to optimize the only protocol for the synthesis of HP-β-CD/Pluronic 
polyrotaxanes in order to develop a synthetic method that can be operated on the multi-gram scale to support 
preclinical studies.
5
 Each component of the protocol was screened to determine which combination lead to the 
formation of polyrotaxanes with the highest yields and threading efficiencies in the shortest amount of time. 
Threading efficiency is a measure of how many HP-β-CD molecules are threaded onto each polymer. In addition 
to optimizing the current protocol, we have also explored flowing the reaction mixture through a bath sonicator 
and using a hydraulic press as alternative syntheses. It was found that probe sonication and bath sonication are 
both necessary components of the protocol. This indicates that sufficient agitation of the reaction mixture is 
required to promote the non-covalent threading reaction. Furthermore, bath sonication for one hour, followed by 
stirring for two days gave the highest threading efficiency. The results of these studies have simplified the 
existing protocol, but additional studies are needed to reveal whether this protocol is robust enough for efficient 
preparation of other HP-β-CD/Pluronic polyrotaxane derivatives. 
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